Japan· JP-6132013M1126
セフジニル
A cefdinir product containing セフジニル, registered in Japan by 長生堂製薬, on the national reimbursement list. The same ATC class is registered in 3 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Cefdinir is registered in 3 of 19 countries.
Countries holding a registration under ATC J01DD15 (cefdinir), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 2 of them publish a price we can compare per daily dose
Cefdinir · ATC J01DD15
3 / 19 countries
- Finlandprice
- Japan
- United Statesprice
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- セフジニル
- Manufacturer
- 長生堂製薬
- Country
- Japan (JP)
- ATC code
- J01DD15
- ATC class
- Cefdinir
- Defined daily dose
- 0.6 g, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
110 interactions on record for cefdinir.
Graded by severity as the source publishes them — 24 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cefdinir · interactions on record
110 records
- 24 moderate
- 86 info
Most severe, free to view
- Magnesium carbonateA02AA01moderate
- Magnesium oxideA02AA02moderate
- Magnesium hydroxideA02AA04moderate
- Kombinationen von AluminiumsalzenA02AB10moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under J01DD15
Cefdinir, as other registers publish it.
- United StatescefdinirAscend Laboratories, LLC
- United StatescefdinirAscend Laboratories, LLC
- United StatescefdinirPreferred Pharmaceuticals Inc.
- United StatescefdinirA-S Medication Solutions
- United StatescefdinirA-S Medication Solutions
- United StatesCefdinirNorthwind Health Company, LLC
- United StatesCefdinirNuCare Pharmaceuticals,Inc.
- United StatesCefdinirTeva Pharmaceuticals USA, Inc.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fb564972-c7e8-4f70-bd41-0390e3c2d2a0 GET /v1/drugs/fb564972-c7e8-4f70-bd41-0390e3c2d2a0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "５０ｍｇ１カプセル",
"marks": "局",
"source": "mhlw",
"remarks": null,
"yj_code": "6132013M1126",
"category": "内用薬",
"price_yen": 52,
"generic_name": "セフジニル",
"product_name_jp": null,
"therapeutic_class": "6132",
"transitional_expiry": null
}See everything about cefdinir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.